IRIS
ROSIELLO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.007
AS - Asia 1.624
NA - Nord America 1.381
SA - Sud America 412
AF - Africa 48
Totale 5.472
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.311
RU - Federazione Russa 1.248
SG - Singapore 610
CN - Cina 459
BR - Brasile 320
SE - Svezia 224
HK - Hong Kong 195
VN - Vietnam 174
IT - Italia 138
DE - Germania 95
FR - Francia 88
GB - Regno Unito 57
IN - India 52
FI - Finlandia 48
BD - Bangladesh 43
AR - Argentina 39
CA - Canada 34
NL - Olanda 28
MX - Messico 25
PL - Polonia 25
ZA - Sudafrica 19
ID - Indonesia 15
IQ - Iraq 15
EC - Ecuador 14
JP - Giappone 14
PE - Perù 12
AT - Austria 9
CO - Colombia 8
ES - Italia 8
LT - Lituania 8
VE - Venezuela 8
IE - Irlanda 7
MA - Marocco 7
MY - Malesia 7
TR - Turchia 7
UZ - Uzbekistan 7
EG - Egitto 5
PK - Pakistan 5
TN - Tunisia 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
CL - Cile 4
NP - Nepal 4
BG - Bulgaria 3
BO - Bolivia 3
KE - Kenya 3
MD - Moldavia 3
PY - Paraguay 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
JO - Giordania 2
PH - Filippine 2
RO - Romania 2
AO - Angola 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KR - Corea 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
UG - Uganda 1
Totale 5.472
Salva come PNG Salva come JPEG
Città #
Singapore 319
Moscow 212
Ashburn 200
Hong Kong 192
Dallas 172
San Jose 147
Shanghai 101
New York 82
Hefei 68
Ho Chi Minh City 66
Lauterbourg 56
Beijing 52
Boardman 50
Lawrence 50
Princeton 50
Los Angeles 47
Milan 36
Munich 35
Hanoi 32
Helsinki 26
São Paulo 26
Santa Clara 23
Warsaw 20
Turku 19
Orem 18
Brooklyn 17
Frankfurt am Main 17
Phoenix 17
Manchester 16
Johannesburg 15
Denver 14
Montreal 14
Rome 14
Chennai 13
Chicago 13
Haiphong 13
Houston 13
Rio de Janeiro 13
Atlanta 12
Guangzhou 12
Mexico City 12
Tokyo 11
Lima 10
Mumbai 10
Poplar 10
Toronto 9
Amsterdam 8
Nuremberg 8
Belo Horizonte 7
Brasília 7
Columbus 7
Council Bluffs 7
Da Nang 7
Falkenstein 7
Hyderabad 7
Shenzhen 7
The Dalles 7
Washington 7
Barnet 6
Biên Hòa 6
Dhaka 6
Dronten 6
Dublin 6
London 6
Manaus 6
Stockholm 6
Tashkent 6
Bologna 5
Pune 5
Querétaro 5
Quito 5
Vienna 5
Borås 4
Boston 4
Brussels 4
Duque de Caxias 4
Guayaquil 4
Hangzhou 4
Hải Dương 4
Ipatinga 4
Jiaxing 4
Las Vegas 4
Ribeirão Preto 4
Salvador 4
San Francisco 4
Seattle 4
Wroclaw 4
Acalanes Ridge 3
Ahmedabad 3
Annapolis 3
Baghdad 3
Bari 3
Belford Roxo 3
Bogotá 3
Buffalo 3
Campinas 3
Canoas 3
Casablanca 3
Cleveland 3
Erbil 3
Totale 2.638
Salva come PNG Salva come JPEG
Nome #
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 180
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 169
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 134
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 129
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 124
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 123
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 122
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 120
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 119
Pulmonary lesion after surgery for renal cancer: progression or new primary? 118
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus 118
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 117
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 115
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study 113
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 112
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 110
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 109
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines 108
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 104
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 102
Influences of Age and Comorbidities on Indication for Partial Nephrectomy: A Systematic Review 98
A machine learning-based analysis for the definition of an optimal renal biopsy for kidney cancer 95
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 94
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 92
Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology 91
Bladder cancer incidence rates and trends in young adults aged 20-39 years 88
Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis 87
Contemporary Rates and Predictors of Open Conversion During Minimally Invasive Radical Prostatectomy for Nonmetastatic Prostate Cancer 84
Effect of Age on Cancer-specific Mortality in Patients with Urothelial Carcinoma of the Urinary Bladder: A Population-based Competing-risks Analysis across Disease Stages 84
Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract 83
Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancer 82
Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium 80
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 78
Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients 77
Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelines 76
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer 76
Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer 76
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis 76
The key role of levator ani thickness for early urinary continence recovery in patients undergoing robot-assisted radical prostatectomy: A multi-institutional study 76
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients 71
Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years 62
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder 62
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis 61
External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSA 60
Erratum: Re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010 (European urology oncology PII: S2588-9311(23)00237-7) 59
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities 58
Salvage pelvic lymph node dissection for lymph node recurrent prostate cancer 57
External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients 57
Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion 56
Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma 55
The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis 52
Rates of other-cause mortality after radical cystectomy are decreasing over time—A population-based analysis over two decades 51
Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study 51
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical nephroureterectomy 49
The effect of systemic chemotherapy on survival in patients with localized, regional, or metastatic adenocarcinoma of the urinary bladder 49
The impact of sex and age on distribution of metastases in patients with renal cell carcinoma 49
Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1–4 cm renal cell carcinomas 47
Re: Stamatio Katsimperis, Lazaros Tzelves, Zafer Tandogdu, et al. Complications After Radical Cystectomy: A Systematic Review and Meta-analysis of Randomized Controlled Trials with a Meta-regression Analysis. Eur Urol Focus 2023;9:920–9 45
Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis 45
Metabolic Syndrome Predicts Worse Perioperative Outcomes in Patients Treated With Partial Nephrectomy for Renal Cell Carcinoma 45
Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma 44
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 44
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities 43
Small renal masses with tumor size 0 to 2 cm: A SEER-based study and validation of NCCN guidelines 43
Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study 42
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy 42
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 41
Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study 41
Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer 34
Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancer 9
Re: Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics 8
Acute kidney injury (AKI) and end stage kidney disease (ESKD) in CKD patients undergoing partial or radical nephrectomy for renal cancer: are we ready to unravel the uncertainty and create new hope? 7
Optimizing oncological outcomes in high-grade non-muscle invasive bladder cancer: The impact of a surgeon-led treatment pathway 4
Surgery or Comorbidities: What Is the Primum Movens of Kidney Dysfunction After Nephrectomy? A Multicenter Study in Living Donors and Cancer Patients 4
Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study 2
Totale 5.588
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.791
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202233 0 2 2 13 2 1 0 0 1 0 1 11
2022/2023358 131 84 35 5 6 42 6 29 15 0 1 4
2023/2024334 20 20 29 21 20 52 8 61 7 9 17 70
2024/20251.034 111 42 54 45 31 79 125 102 134 135 77 99
2025/20263.784 255 244 264 460 323 100 266 320 1.084 212 149 107
Totale 5.588